Legend Biotech Corporation American Depositary Shares LEGN
$17.50
-5.61%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (5 Buy · 4 Hold · 0 Sell)
- Average Price Target
- $44.78
- Implied Upside
- +155.9%
- Price Target Range
- $24.00 – $74.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-11 | OppenheimerKostas Biliouris |
Maintains | Perform | $40 → $25 |
| 2026-11-11 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $49 → $43 |
| 2026-11-11 | BarclaysEtzer Darout |
Maintains | Overweight | $68 → $61 |
| 2026-11-11 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $56 → $50 |
| 2026-10-13 | BarclaysEtzer Darout |
Maintains | Overweight | $74 → $68 |
| 2026-10-09 | JP MorganJessica Fye |
Maintains | Neutral | $35 → $33 |
| 2026-10-08 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $58 → $56 |
| 2026-09-30 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $65 |
| 2026-09-11 | BarclaysEtzer Darout |
Maintains | Overweight | $78 → $74 |
| 2026-09-04 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $65 |
| 2026-08-12 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $48 → $49 |
| 2026-08-12 | TD CowenYaron Werber |
Maintains | Hold | $29 → $24 |
| 2026-08-12 | OppenheimerTrevor Allred |
Downgrades | Outperform → Perform | $75 → $40 |
| 2026-08-12 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $59 → $58 |
| 2026-08-12 | BarclaysEtzer Darout |
Maintains | Overweight | $80 → $78 |
| 2026-07-28 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $65 |
| 2026-07-27 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $63 → $59 |
| 2026-07-24 | UBSAshwani Verma |
Downgrades | Buy → Neutral | $49 → $28 |
| 2026-07-13 | JP MorganJessica Fye |
Reinstates | Neutral | $35 |
| 2026-07-07 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $64 → $63 |
| 2026-06-03 | UBSAshwani Verma |
Maintains | Buy | $31 → $49 |
| 2026-06-03 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $50 → $65 |
| 2026-05-18 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $50 |
| 2026-05-13 | TD CowenYaron Werber |
Maintains | Hold | $21 → $29 |
| 2026-05-13 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $49 → $48 |
| 2026-05-13 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $62 → $64 |
| 2026-04-21 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $50 |
| 2026-04-15 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $50 |
| 2026-03-11 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $50 → $49 |
| 2026-03-11 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $66 → $62 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $17.50
- Market Cap
- $3.60 billion
- 52-Week Range
- $16.24 – $37.50
- Average Volume
- 2.36 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.